Amos Éla Bella

454 citations
18 papers · 346 indexed · h-index 9
Topics
Esophageal Cancer Research and Treatment (9 papers)Esophageal and GI Pathology (5 papers)Lung Cancer Diagnosis and Treatment (5 papers)

In The Last Decade

Amos Éla Bella

17 papers receiving 345 citations

Peers

Amos Éla Bella
Comparison fields: 5 of 55
  • Surgery 210
  • Pulmonary and Respiratory Medicine 202
  • Oncology 91
  • Molecular Biology 53
  • Physiology 35
Replace Jialong Li with:
Jialong Li China
M. Polée Netherlands
Tomohiko Nishi Japan
Shi-Liang Liu China
Yasunari Ubukata Japan
Ryuichiro Sawada Japan
Meiqing Xu China
Jun-Peng Lin China
Azusa Komori Japan
Masanori Shimomura Japan
Amos Éla Bella relative to Jialong Li China Jialong Li's profile →
Citations per field
00.5×10×15×20×22.5×
Jialong Li · 1×
Citations per year

Countries citing papers authored by Amos Éla Bella

Since Specialization
Citations

This map shows the geographic impact of Amos Éla Bella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Éla Bella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Éla Bella more than expected).

Fields of papers citing papers by Amos Éla Bella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Éla Bella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Éla Bella. The network helps show where Amos Éla Bella may publish in the future.

Co-authorship network of co-authors of Amos Éla Bella

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Éla Bella. A scholar is included among the top collaborators of Amos Éla Bella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Éla Bella. Amos Éla Bella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 3
3 13
4 6
5 15
6 22
7 32
8 25
9 30
10 120
11 48
12 1
13 15
14
[A new retrievable nitinol alloy stents for treatment of refractory benign esophageal strictures].
1
15 4
16 7
17 1
18 3

About Amos Éla Bella

Amos Éla Bella is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 346 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Esophageal and GI Pathology (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (202 citations), Surgery (210 citations) and Oncology (91 citations). Amos Éla Bella has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianhua Fu, Jing Wen, Fengwen Yang, Kaijun Luo, Qingyuan Huang, Qianwen Liu, Hong Yang, Yonghong Hu, Xiaoming Xie and Zhenguang Chen. Their work appears in journals such as PLoS ONE, British Journal of Cancer and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026